| | | |
 
 
Health care team
 Quick Links
 
     
 

Cardiothoracic surgery faculty

Sanjiv Gandhi, MD,

Pediatric Cardiovascular and Thoracic Surgeon
 
Appointments
 
Division of Pediatric Cardiovascular and Thoracic Surgery, BC Children’s Hospital

Bio

 

Credentials
 

top of page

 

Andrew Campbell, MD, FRCS(C)


Pediatric Cardiac Surgeon
 
Appointment
 
Division of Pediatric Cardiac Surgery, Children’s Hospital of British Columbia
Assistant Professor, University of British Columbia
 
Bio
 
Dr. Campbell’s main interests in clinical practice are in the areas of neonatal cardiac surgery and thoracic organ transplantation.
 
Dr. Campbell trained in pediatric cardiac surgery at the Hospital for Sick Children in Toronto, Canada and at the Children’s Hospital of Philadelphia. He was subsequently recruited to the Children’s Hospital of Philadelphia and operated there and at the Children’s Hospital of New Jersey in Newark.
 
From 1996 to 1999 Dr. Campbell was a research fellow at the Terrence Donneley Vascular Biology Laboratory at St. Michael’s Hospital in Toronto. He developed novel methods of gene transfer in the laboratory and developed the first human Canadian protocol for DNA transfer to the heart.
 
Credentials
 
Bachelor of Medical Science and M.D., University of Ottawa, Canada: 1989-1993.
Fellow of the Royal College of Surgeons of Canada in Cardiac Surgery: 2001
Fellow in Cardiac Surgery at the Hospital for Sick Children: 2001
Fellow in Cardiac Surgery at the Children’s Hospital of Philadelphia: 2002

Awards and honors
 
Gallie-Bateman Award, First Prize for resident research in the Department of Surgery, University of Toronto, 1999
C. Walton Lillehei Award for outstanding research at the American Association of Thoracic Surgery, 1999
 
Publications, most recent
 
1. Campbell AIM, Kuliszewski MA, Stewart DJ. Cell-based gene transfer to the pulmonary vasculature: endothelial NO synthase overexpression inhibits monocrotaline-induced pulmonary hypertension. American Journal of Respiratory Cell and Molecular Biology 21(5): 567-575, 1999.
2. Teichert-Kuliszewska K, Maisonpierre PC, Jones N, Campbell A, Master Z, Bendeck MP, Alitalo K, Dumont DJ, Yancopoulos GD, Stewart DJ. Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2. Cardiovascular Research 49(3):659-70, 2001
3. Campbell AIM, Zhao YD, Sandhu R, Stewart DJ. Cell-based gene transfer of VEGF attenuates monocrotaline-induced pulmonary hypertension. Circulation 104(18):2242-8, 2001
4. Konstantinov I, Van Arsdell GS, O'Blenes S, Roy N, Campbell A. The retro-aortic inominate vein with coarctation of the aorta: Surgical repair and embryology review. Annals of Thoracic Surgery. Annals of Thoracic Surgery 75(3):1014-6, 2003
5. O'Blenes SB, Merklinger SL, Jegatheeswaran A, Campbell A, Rabinovitch M, Rebeyka I, Van Arsdell G. Low molecular weight heparin and unfractionated heparin are both effective at accelerating pulmonary vascular maturation in neonatal rabbits. Circulation 108(9):II161-6, 2003
6. Zhao YD, Campbell AI, Robb M, Ng D, Stewart DJ. Protective role of angiopoietin-1 in experimental pulmonary hypertension. Circulation Research 92(9):984-91, 2003
7. Sandhu R, Teichert-Kuliszewska K, Nag S, Proteau G, Robb, MJ, Campbell AIM, Kuliszewski M, Kutryk MJB, Stewart DJ. Reciprocal regulation of angiopoietin-1 and angiopoietin-2 following myocardial infarction in the rat. Cardiovascular Research 64(1):115-24, 2004
 
Presentations
 
Campbell AIM, Latter DA, Stewart DJ. Adjunctive gene therapy with VEGF165: A preliminary Canadian experience. Canadian Cardiovascular Society, Vancouver, October 2000. Oral presentation.
 
Special interests
 
Dr. Campbell’s principal research interest is in the genetic manipulation of lung development and pulmonary hypertension in children.

 

top of page